Increased Risk of Virologic Rebound in Patients on Antiviral Therapy with a Detectable HIV Load <48 Copies/mL

Open Access

Peer-reviewed

Research Article

Timothy J. Henrich ,

Contributed equally to this work with: Timothy J. Henrich, Brian R. Wood

* E-mail: thenrich@partners.org

Affiliation Division of Infectious Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Brian R. Wood ,

Contributed equally to this work with: Timothy J. Henrich, Brian R. Wood

Affiliation Division of Infectious Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Daniel R. Kuritzkes

Affiliation Division of Infectious Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
⨯

Reader Comments (0)

Viral load
Is the Subject Area "Viral load" applicable to this article?

Thanks for your feedback.
Viremia
Is the Subject Area "Viremia" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
HIV-1
Is the Subject Area "HIV-1" applicable to this article?

Thanks for your feedback.
Reverse transcriptase-polymerase chain reaction
Is the Subject Area "Reverse transcriptase-polymerase chain reaction" applicable to this article?

Thanks for your feedback.
Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Antiretrovirals
Is the Subject Area "Antiretrovirals" applicable to this article?

Thanks for your feedback.
T helper cells
Is the Subject Area "T helper cells" applicable to this article?

Thanks for your feedback.